Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 7/20 | 0.53 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.49 |
| ▸ | ACE | P12821 | 2/20 | 0.49 |
| ▸ | CTSC | P53634 | 1/20 | 0.49 |
| ▸ | ECE1 | P42892 | 1/20 | 0.48 |
| ▸ | NPBWR1 | P48145 | 2/20 | 0.48 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.48 |
| ▸ | GHSR | Q92847 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30092926 | 0.96 | ACE (0.51) | KISS1RACECTSCECE1NPBWR1 | |
| SCHEMBL30092954 | 0.96 | KISS1R (0.52) | KISS1RACECTSCECE1PRMT1 | |
| SCHEMBL30092902 | 0.96 | KISS1R (0.52) | KISS1RACECTSCECE1PRMT1 | |
| SCHEMBL31165840 | 0.93 | ACE (0.54) | KISS1RACECTSCECE1GHSR | |
| SCHEMBL31165849 | 0.91 | ACE (0.56) | KISS1RACECTSCECE1GHSR | |
| SCHEMBL31345040 | 0.91 | KISS1R (0.56) | KISS1RACEECE1NPBWR1PRMT1 | |
| SCHEMBL30750952 | 0.90 | ERAP2 (0.53) | KISS1RACECTSCECE1GHSR | |
| SCHEMBL29732261 | 0.89 | IL23R (0.51) | KISS1RACECTSCECE1GHSR | |
| SCHEMBL31286296 | 0.89 | GHSR (0.57) | ACENPBWR1GHSR | |
| SCHEMBL29799990 | 0.89 | IL23R (0.51) | KISS1RACECTSCECE1GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220073446-A1 | Antigen Delivery Vectors and Constructs | ALTIMMUNE UK LIMITED (GB) | 2022-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220073446-A1 | Antigen Delivery Vectors and Constructs | LY96, CD74, CD69 | KISS1R 4112/4885CXCR4 363/4885ACE 1068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.